• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液和血浆中神经丝轻链升高反映神经结节病的炎症性磁共振成像活动。

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis.

作者信息

Byg Keld-Erik, Nielsen Helle H, Sejbaek Tobias, Madsen Jonna Skov, Olsen Dorte Aalund, Nguyen Nina, Kindt Astrid, Grauslund Jakob, Illes Zsolt, Ellingsen Torkell

机构信息

Department of Neurology, Odense University Hospital, J.B. Winsloewsvej 4, 5000 Odense, Denmark.

BRIDGE-Brain Research-Inter-Disciplinary Guided Excellence, Department of Clinical Research, University of Southern Denmark, J.B. Winsloesvej 19, 5000 Odense, Denmark.

出版信息

Brain Sci. 2021 Feb 14;11(2):238. doi: 10.3390/brainsci11020238.

DOI:10.3390/brainsci11020238
PMID:33672795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7918492/
Abstract

BACKGROUND

Damage to axonal cells releases neurofilament light chain (NFL) into the cerebrospinal fluid and plasma. The objective of this study was to investigate NFL as a potential biomarker of disease activity in neurosarcoidosis. MRIs were graded according to enhancing lesions at different central nervous system (CNS) sites.

RESULTS

In cerebrospinal fluid, levels of NFL were higher in neurosarcoidosis patients ( = 20) median 2304 pg/mL (interquartile range (IQR) 630-19,612) compared to 426 pg/mL (IQR 261-571) in extra-neurologic sarcoidosis patients ( = 20) and 336 pg/mL (IQR 194-402) in healthy controls ( = 11) ( = 0.0002). In plasma, levels of NFL were higher in neurosarcoidosis patients median 28.2 pg/mL (IQR 11.5-49.3) compared to 6.2 pg/mL (IQR 4.3-8.2) in extra-neurologic sarcoidosis patients and 7.1 pg/mL (IQR 6.2-9.0) in healthy controls ( = 0.0001). Levels in both cerebrospinal fluid and plasma were higher in neurosarcoidosis patients with moderate/severe enhancement than patients with mild enhancement on MRI ( = 0.009 and = 0.005, respectively). To distinguish neurosarcoidosis patients from extra-neurologic patients and healthy controls, a cut-off level of 630 pg/mL in cerebrospinal fluid had 94% specificity and 79% sensitivity, while a cut-off level of 11.4 pg/mL in plasma had 97% specificity and 75% sensitivity.

CONCLUSIONS

NFL levels in cerebrospinal fluid and plasma are significantly higher in neurosarcoidosis patients compared to extra-neurologic patients and healthy controls, and the levels correlate to the extent of inflammation on MRI.

摘要

背景

轴突细胞损伤会将神经丝轻链(NFL)释放到脑脊液和血浆中。本研究的目的是调查NFL作为神经结节病疾病活动潜在生物标志物的情况。MRI根据不同中枢神经系统(CNS)部位的强化病变进行分级。

结果

在脑脊液中,神经结节病患者(n = 20)的NFL水平中位数为每毫升2304皮克(四分位间距(IQR)630 - 19,612),高于非神经结节病患者(n = 20)的每毫升426皮克(IQR 261 - 571)和健康对照者(n = 11)的每毫升336皮克(IQR 194 - 402)(P = 0.0002)。在血浆中,神经结节病患者的NFL水平中位数为每毫升28.2皮克(IQR 11.5 - 49.3),高于非神经结节病患者的每毫升6.2皮克(IQR 4.3 - 8.2)和健康对照者的每毫升7.1皮克(IQR 6.2 - 9.0)(P = 0.0001)。与MRI轻度强化的神经结节病患者相比,中度/重度强化患者的脑脊液和血浆中NFL水平均更高(分别为P = 0.009和P = 0.005)。为区分神经结节病患者与非神经疾病患者及健康对照者,脑脊液中630皮克/毫升的截断值具有94%的特异性和79%的敏感性,而血浆中11.4皮克/毫升的截断值具有97%的特异性和75%的敏感性。

结论

与非神经疾病患者和健康对照者相比,神经结节病患者脑脊液和血浆中的NFL水平显著更高,且这些水平与MRI上的炎症程度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc2/7918492/b1c0f89a96e9/brainsci-11-00238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc2/7918492/699df008831a/brainsci-11-00238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc2/7918492/b1c0f89a96e9/brainsci-11-00238-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc2/7918492/699df008831a/brainsci-11-00238-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfc2/7918492/b1c0f89a96e9/brainsci-11-00238-g002.jpg

相似文献

1
Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis.脑脊液和血浆中神经丝轻链升高反映神经结节病的炎症性磁共振成像活动。
Brain Sci. 2021 Feb 14;11(2):238. doi: 10.3390/brainsci11020238.
2
CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration.原发性进行性多发性硬化症患者脑脊液中神经丝轻链水平:轴突神经变性的迹象
Front Neurol. 2018 Dec 14;9:1037. doi: 10.3389/fneur.2018.01037. eCollection 2018.
3
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.神经结节病中脑脊液 CD4/CD8 比值及白介素-6 和 -10 水平:一项多中心、实用、对比研究。
Eur J Neurol. 2019 Oct;26(10):1274-1280. doi: 10.1111/ene.13975. Epub 2019 Jun 24.
4
Evaluating S100B as a serum biomarker for central neurosarcoidosis.评估 S100B 作为中枢神经结节病的血清生物标志物。
Respir Med. 2020 Feb;162:105855. doi: 10.1016/j.rmed.2019.105855. Epub 2019 Dec 21.
5
Evaluation of Plasma Neurofilament Light Chain Levels as a Biomarker of Neuronal Injury in the Active and Chronic Phases of Autoimmune Neurologic Disorders.评估血浆神经丝轻链水平作为自身免疫性神经系统疾病活动期和慢性期神经元损伤生物标志物的研究。
Front Neurol. 2022 Mar 2;13:689975. doi: 10.3389/fneur.2022.689975. eCollection 2022.
6
Neurofilament light chain as a biomarker of meningoencephalitis of unknown etiology in dogs.神经丝轻链作为犬不明病因脑膜脑炎的生物标志物。
J Vet Intern Med. 2021 Jul;35(4):1865-1872. doi: 10.1111/jvim.16184. Epub 2021 Jun 10.
7
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.抗抗体介导性脑炎患者的血清和脑脊液神经丝轻链水平。
J Neurol. 2019 Jul;266(7):1643-1648. doi: 10.1007/s00415-019-09306-z. Epub 2019 Apr 3.
8
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.脑脊髓液神经丝轻链蛋白水平与痴呆、运动神经元病和运动障碍患者认知的相关性。
JAMA Neurol. 2019 Mar 1;76(3):318-325. doi: 10.1001/jamaneurol.2018.3746.
9
Neurosarcoidosis: correlation of cerebrospinal fluid findings with diffuse leptomeningeal gadolinium enhancement on MRI and clinical disease activity.神经结节病:脑脊液检查结果与 MRI 显示弥漫性软脑膜钆增强及临床疾病活动的相关性。
J Neurol Sci. 2013 Dec 15;335(1-2):124-30. doi: 10.1016/j.jns.2013.09.008. Epub 2013 Sep 11.
10
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies.血清和脑脊液神经丝轻链水平在获得性周围神经病患者中的变化。
J Peripher Nerv Syst. 2018 Sep;23(3):174-177. doi: 10.1111/jns.12279. Epub 2018 Jul 24.

引用本文的文献

1
Increased CXCL12, a potential CSF biomarker for differential diagnosis of amyotrophic lateral sclerosis.趋化因子CXCL12升高,一种用于肌萎缩侧索硬化症鉴别诊断的潜在脑脊液生物标志物。
Brain Commun. 2024 Aug 13;6(4):fcae271. doi: 10.1093/braincomms/fcae271. eCollection 2024.
2
Cerebrospinal Fluid Biomarkers in Differential Diagnosis of Multiple Sclerosis and Systemic Inflammatory Diseases with Central Nervous System Involvement.脑脊液生物标志物在多发性硬化症和累及中枢神经系统的全身性炎症性疾病鉴别诊断中的应用
Biomedicines. 2023 Feb 1;11(2):425. doi: 10.3390/biomedicines11020425.
3
CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.

本文引用的文献

1
Comparison of neurofilament light chain results between two independent facilities.两个独立机构之间神经丝轻链结果的比较。
BMJ Neurol Open. 2020 Oct 19;2(2):e000063. doi: 10.1136/bmjno-2020-000063. eCollection 2020.
2
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.神经丝轻链是狼疮和原发性干燥综合征脑受累的生物标志物。
J Neurol. 2021 Apr;268(4):1385-1394. doi: 10.1007/s00415-020-10290-y. Epub 2020 Oct 30.
3
Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.
脑脊液神经丝轻链在 NMDAR 和 LGI1 脑炎中的水平:一项全国性队列研究。
Front Immunol. 2021 Dec 16;12:719432. doi: 10.3389/fimmu.2021.719432. eCollection 2021.
4
Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies.神经丝蛋白作为监测神经疾病及治疗效果的生物标志物。
Front Neurosci. 2021 Sep 27;15:689938. doi: 10.3389/fnins.2021.689938. eCollection 2021.
分析可溶性白细胞介素-2 受体作为神经结节病的 CSF 生物标志物。
Neurol Neuroimmunol Neuroinflamm. 2020 May 11;7(4). doi: 10.1212/NXI.0000000000000725. Print 2020 Jul.
4
Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis: A retrospective study.基于脑脊液分析鉴别神经结节病与多发性硬化症:一项回顾性研究。
Neurology. 2020 Jun 16;94(24):e2545-e2554. doi: 10.1212/WNL.0000000000009491. Epub 2020 Apr 30.
5
Serum neurofilament light levels in normal aging and their association with morphologic brain changes.血清神经丝轻链水平在正常衰老中的变化及其与形态学脑改变的关系。
Nat Commun. 2020 Feb 10;11(1):812. doi: 10.1038/s41467-020-14612-6.
6
Evaluating S100B as a serum biomarker for central neurosarcoidosis.评估 S100B 作为中枢神经结节病的血清生物标志物。
Respir Med. 2020 Feb;162:105855. doi: 10.1016/j.rmed.2019.105855. Epub 2019 Dec 21.
7
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD.血清 GFAP 和神经丝轻链作为 NMOSD 疾病活动和残疾的生物标志物。
Neurology. 2019 Sep 24;93(13):e1299-e1311. doi: 10.1212/WNL.0000000000008160. Epub 2019 Aug 30.
8
The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study.神经结节病中脑脊液 CD4/CD8 比值及白介素-6 和 -10 水平:一项多中心、实用、对比研究。
Eur J Neurol. 2019 Oct;26(10):1274-1280. doi: 10.1111/ene.13975. Epub 2019 Jun 24.
9
Neurofilament light chain as a biomarker in neurological disorders.神经丝轻链作为神经紊乱的生物标志物。
J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):870-881. doi: 10.1136/jnnp-2018-320106. Epub 2019 Apr 9.
10
Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.抗逆转录病毒治疗的 HIV 感染患者中,脑脊液细胞外囊泡和神经丝轻链蛋白作为中枢神经系统损伤的生物标志物。
AIDS. 2019 Mar 15;33(4):615-625. doi: 10.1097/QAD.0000000000002121.